The round also includes participation from Plug & Play Ventures and Wealthing VC Club. The capital will be used to accelerate the use of iQuest, an AI-enabled patient management software that identifies and visualizes a patient's prostate cancer. The funding will also be used to continue clinical evidence development.

Avenda Health is creating a more personalized future of prostate cancer care. Using deep learning, Avenda Health software maps a patient's cancer in 3D, giving physicians precise information and the confidence to make care decisions. Dedicated to bringing this cutting-edge technology to all practices and physicians treating prostate cancer patients, Avenda Health aims to improve outcomes, preserve quality of life, and create a new standard of cancer care.